Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
The Cervical Cancer Prevention in El Salvador (CAPE) project is a public-sector intervention introducing lower-cost human papillomavirus (HPV) testing in all four departments of the Paracentral region that screened a total of 28,015 women. After demonstrating success of an HPV screen-and-treat (S&T) algorithm over colposcopy management in the first two phases, the third phase scaled up the S&T strategy. We present results from phase III and evaluate S&T components across the entire project. During phase III, 17,965 women age 30-59 years underwent HPV testing. HPV-positive women were asked to return and, if eligible, received gas-based cryotherapy. We compare loss to follow-up and time intervals between S&T steps across the three phases. There were no differences in HPV positivity across phases (phase I, 11.9%; phase II, 11.4%; phase III, 12.3%; A public-sector implementation of an HPV-based S&T algorithm was successfully scaled up in El Salvador, albeit with losses in efficiency. After CAPE, the Ministry of Health changed its screening guidelines and procured additional tests to expand the program.
Identifiants
pubmed: 33064628
doi: 10.1200/GO.20.00206
pmc: PMC7605377
doi:
Types de publication
Clinical Trial, Phase III
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1519-1530Références
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Salud Publica Mex. 2016 Apr;58(2):197-210
pubmed: 27557378
AIDS. 2010 Oct 23;24(16):2553-61
pubmed: 20706107
J Low Genit Tract Dis. 2016 Apr;20(2):145-50
pubmed: 26890683
Int J Cancer. 2015 Aug 15;137(4):893-902
pubmed: 25639903
J Low Genit Tract Dis. 2017 Jan;21(1):26-32
pubmed: 27922905
Stat Med. 1985 Oct-Dec;4(4):543-7
pubmed: 4089356
JAMA. 2001 Jun 27;285(24):3107-15
pubmed: 11427139
Int J Cancer. 2015 Oct 1;137(7):1709-18
pubmed: 25807897
Int J Gynaecol Obstet. 2019 Apr;145(1):40-46
pubmed: 30702142
Cochrane Database Syst Rev. 2017 Aug 10;8:CD008587
pubmed: 28796882
Int J Womens Health. 2017 Dec 01;9:879-886
pubmed: 29238232
JAMA. 2005 Nov 2;294(17):2173-81
pubmed: 16264158
N Engl J Med. 2005 Nov 17;353(20):2158-68
pubmed: 16291985
BMC Womens Health. 2017 Jan 7;17(1):2
pubmed: 28061842
Cancer Prev Res (Phila). 2013 Sep;6(9):938-48
pubmed: 23878179
Lancet Oncol. 2008 Oct;9(10):929-36
pubmed: 18805733
Lancet Public Health. 2017 Feb;2(2):e96-e107
pubmed: 29253402
Vaccine. 2008 Aug 19;26 Suppl 11:L37-48
pubmed: 18945401
Lancet Glob Health. 2015 Feb;3(2):e85-94
pubmed: 25617202
Prev Med. 2018 Sep;114:149-155
pubmed: 29958860